- Home
- VREX vs INBX Comparison
VREX vs INBX Comparison
Compare VREX & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VREX
- INBX
- Stock Information
- Founded
- VREX 2016
- INBX 2010
- Country
- VREX United States
- INBX United States
- Employees
- VREX N/A
- INBX N/A
- Industry
- VREX Industrial Machinery/Components
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- VREX Technology
- INBX Health Care
- Exchange
- VREX Nasdaq
- INBX Nasdaq
- Market Cap
- VREX 483.7M
- INBX 430.2M
- IPO Year
- VREX N/A
- INBX 2020
- Fundamental
- Price
- VREX $11.55
- INBX $83.81
- Analyst Decision
- VREX Strong Buy
- INBX Hold
- Analyst Count
- VREX 3
- INBX 2
- Target Price
- VREX $16.67
- INBX N/A
- AVG Volume (30 Days)
- VREX 345.2K
- INBX 358.1K
- Earning Date
- VREX 11-18-2025
- INBX 11-14-2025
- Dividend Yield
- VREX N/A
- INBX N/A
- EPS Growth
- VREX N/A
- INBX N/A
- EPS
- VREX N/A
- INBX N/A
- Revenue
- VREX $844,600,000.00
- INBX $1,400,000.00
- Revenue This Year
- VREX $3.83
- INBX $563.00
- Revenue Next Year
- VREX $4.77
- INBX $230.77
- P/E Ratio
- VREX N/A
- INBX N/A
- Revenue Growth
- VREX 4.14
- INBX N/A
- 52 Week Low
- VREX $6.76
- INBX $10.81
- 52 Week High
- VREX $16.93
- INBX $87.84
- Technical
- Relative Strength Index (RSI)
- VREX 50.13
- INBX 68.26
- Support Level
- VREX $10.09
- INBX $78.26
- Resistance Level
- VREX $12.35
- INBX $87.84
- Average True Range (ATR)
- VREX 0.68
- INBX 6.53
- MACD
- VREX -0.07
- INBX -1.12
- Stochastic Oscillator
- VREX 60.39
- INBX 75.78
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.